Table 1.
All patients (n = 275) |
Ctrl (n = 237) |
aoVA (n = 38) |
P | ||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
Total number of patients | 275 | 100.0 | 237 | 86.2 | 38 | 13.8 | — |
Age at diagnosis, mean (SD), years | 67.6 | 12.3 | 68.0 | 12.7 | 65.3 | 9.4 | .115 |
Gender | |||||||
Female | 118 | 42.8 | 96 | 40.5 | 22 | 56.4 | .092 |
Male | 158 | 57.2 | 141 | 59.5 | 17 | 43.6 | |
Body mass index | |||||||
<25 | 102 | 45.9 | 84 | 45.2 | 18 | 50.0 | .639 |
25-29.9 | 91 | 41.0 | 76 | 40.9 | 15 | 41.7 | |
30+ (obese) | 29 | 13.1 | 26 | 14.0 | 3 | 8.30 | |
Histology | |||||||
ADC | 135 | 48.9 | 114 | 48.1 | 21 | 53.8 | .953 |
SQC | 123 | 44.6 | 107 | 45.1 | 16 | 41.0 | |
LCC | 18 | 6.5 | 16 | 6.8 | 2 | 5.1 | |
Smoker | |||||||
Current/past | 216 | 94.3 | 183 | 94.8 | 33 | 91.7 | .720 |
Never | 13 | 5.70 | 10 | 5.2 | 3 | 8.30 | |
Cancer-directed surgeryc | |||||||
No | 110 | 39.9 | 93 | 39.2 | 17 | 43.6 | .736 |
Yes | 166 | 60.1 | 144 | 60.8 | 22 | 56.4 | |
Chemotherapy | |||||||
No | 185 | 67.0 | 170 | 71.7 | 15 | 38.5 | 9.172e-05 |
Yes | 91 | 33.0 | 67 | 28.3 | 24 | 61.5 | |
Radiation therapy (lung) | |||||||
No | 250 | 90.6 | 215 | 90.7 | 35 | 89.7 | 1.0 |
Yes | 26 | 9.4 | 22 | 9.3 | 4 | 10.3 | |
Partner status | |||||||
Married/life partnership | 114 | 41.3 | 93 | 39.1 | 12 | 30.8 | .211 |
Living alone | 62 | 22.5 | 56 | 23.6 | 6 | 15.4 | |
NA | 100 | 36.2 | 88 | 37.2 | 12 | 30.8 |
Abbreviations: Ctrl, control group; aoVA, add-on Viscum album L, SD, standard deviation; ADC, adenocarcinoma; SQC, squamous cell carcinoma; LCC, large cell carcinoma; NA, not specified.
Characteristics of patients with stages I to IIIA non–small cell lung cancer; percentages of sub-characteristics may not add up to 100% due to rounding procedures.
Chi-square analysis for categorical variables (or Fisher’s exact test in case frequencies were ≤5); Student’s t test for age distribution.
In one patient, cancer-directed surgery was not specified.